文献速递主动脉疾病内脏/肾动脉与血管畸形

内脏动脉支架移植物原位激光开窗术(InLoVE):多中心研究中远期结果

In situ Laser Fenestration of Visceral Endografts (InLoVE): Midterm Outcomes from a Multicentre Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2024-12-31

该多中心回顾性研究汇总2018至2023年三个主动脉中心连续34例患者共65例次内脏动脉支架移植物原位激光开窗术,79%为急性手术、35%为破裂,技术成功率94%(61/65),30天死亡12%(4例,均为破裂),中位随访16个月,6个月至随访结束免于靶血管不稳定为89%,结论认为该技术是复杂解剖急诊腔内手术的有前景工具。

要点

  • 34例患者共65例次原位激光开窗术,平均年龄74岁,79%为急性手术,35%为破裂。
  • 技术成功61/65(94%),失败均为肾动脉(3例角度困难、1例插管时夹层)。
  • 中位随访16个月,6个月至随访结束免于靶血管不稳定89%,最终桥接支架通畅率100%(61/61)。

核心结论

  • 原位激光开窗术是复杂解剖急诊腔内手术的有前景工具。

研究设计与样本

  • 回顾性汇总三个主动脉中心2018至2023年连续实施的内脏动脉支架移植物原位激光开窗术病例,共34例患者65例次手术,平均年龄74岁。

主要发现

  • 手术为急性者占79%,破裂占35%;预置支架于56个靶血管(86%)。
  • 30天内4例(12%)死亡,均表现为破裂。
  • 65例次原位激光开窗术中技术成功61例次(94%),失败均为肾动脉:3例因角度困难、1例在插管时发生夹层。
  • 中位随访16个月(四分位距5,22),6个月、1年、2年累积生存率分别为88%、81%、72%。
  • 检出6例(10%)靶血管不稳定:2例(3%)III型内漏和4例(7%)支架狭窄,均需重新衬附;6个月至随访结束免于靶血管不稳定的比例为89%;末次随访扫描所有成功部署的原位激光开窗桥接支架均通畅(一期辅助通畅率100%;61/61),无III型内漏征象。

关键数值与推荐

  • 技术成功定义为桥接支架成功血管化且最终血管造影图像可接受、无桥接支架相关内漏征象。
  • 靶血管不稳定定义为桥接支架相关内漏、断开、扭结、狭窄、桥接支架闭塞、针对桥接支架的再干预,或桥接支架相关破裂或死亡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Emergency complex abdominal aortic diseases are challenging to treat. During in situ laser fenestration (ISLF), aortic branches are covered and flow is restored by in situ fenestration of the stent graft, with promising midterm results. This study aimed to expand on the limited body of knowledge of midterm outcomes of ISLF in renovisceral aortic pathology in a multicentre setting. METHODS: Retrospective pooled data on consecutive ISLF cases of visceral aortic stent grafts undertaken between 2018 - 2023 in three aortic centres were analysed. Technical success was defined as successful vascularisation with a bridging stent graft and acceptable final angiographic images without signs of endoleak related to the bridging stent graft. Target vessel instability was defined as an endoleak related to the bridging stent graft, disconnection, kink, stenosis, occlusion of bridging stent, re-intervention to the bridging stent graft, or rupture or death related to the bridging stent graft. RESULTS: Sixtyfive ISLFs were performed in 34 patients, with a mean age 74 years. The procedure was acute in 79%, and 35% were ruptures. Pre-stenting was performed on 56 target vessels (86%). Four patients (12%) died within 30 days; all presented with a rupture. Technical success was achieved in 61 of 65 (94%) ISLFs. All failed cannulations were in the renal arteries: three due to difficult angulations and one dissected during cannulation. Median follow up was 16 (interquartile range 5, 22) months. Cumulative survival at six months, one, and two years was 88%, 81%, and 72%, respectively. Six (10%) target vessel instabilities were detected: two (3%) type III endoleaks and four (7%) stent stenosis; all of which required re-lining. Freedom from target vessel instability at six months until the end of follow up was 89%. On the latest follow up scan, all successfully deployed ISLF bridging stents were patent (primary assisted patency 100%; 61 of 61) without signs of type III endoleak. CONCLUSION: ISLF is a promising tool for emergency endovascular procedures in complex anatomies.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Jónsson GG, Zielinski AH, Berczeli M, et al. In situ Laser Fenestration of Visceral Endografts (InLoVE): Midterm Outcomes from a Multicentre Study. Eur J Vasc Endovasc Surg. 2024. PMID: 39746568. doi:10.1016/j.ejvs.2024.12.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。